# BD Medical opens third world-class production base in Yixing, China

BD Medical (Becton, Dickinson and Company) announced the official opening of its third world-class production base in Yixing, Jiangsu, China. The facility, with a total investment of 1.332 billion RMB, covers 54 mu (3.6 hectares) and 35,000 square meters, and is expected to produce 250 million liters of bottled injections and 400 million prefilled saline syringes annually.

- Type: New facility
- Announced: 2024-12-20
- Where: Yixing, Jiangsu, China
- Value: $183.0M (1.33B CNY)
- Starts operating: 20 Dec 2024
- Status: completed
- Capacity: 250 million liters of bottled injections and 400 million prefilled saline syringes per year
- Products: bottled injections, prefilled saline syringes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Becton Dickinson & Co](https://endata.com/companies/20401.md)

## Sources

- [sh.chinanews.com.cn](https://www.sh.chinanews.com.cn/yljk/2024-12-20/131720.shtml), 2024-12-20: "碧迪医疗20日在沪披露，其在中国的第三座世界级本土生产基地正式投入运营，该基地位于江苏宜兴。"
- [flcube.com](https://flcube.com/becton-dickinson-and-co-launches-rmb1-332-billion-factory-in-jiangsu-for-pre-filled-syringes/), 2024-12-23: "US-based Becton, Dickinson and Co., (BD) has officially put into operation its new factory in Yixing, Jiangsu province, with an investment worth RMB1.332 billion (USD182.5 million)."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.